EN
登录

Tempus与Cigna签订网络内医疗服务提供商协议,扩大下一代测序检验服务范围

Tempus Expanding Access to its Next-Generation Sequencing Tests as an In-Network Provider for Cigna

businesswire 等信源发布 2024-02-21 21:30

可切换为仅中文


CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the company has signed an agreement for in-network provider status with Cigna Healthcare. The collaboration signifies an important stride in enhancing accessibility to Tempus' array of molecular profiling tests for Cigna's extensive network, which comprises approximately 16 million members..

芝加哥--(商业新闻短讯)--人工智能和精准医学领域的领导者Tempus今天宣布,该公司已与Cigna Healthcare签署了网络提供商身份协议。此次合作标志着在增强Tempus针对信诺广泛网络的一系列分子分析测试的可及性方面迈出了重要的一步,信诺广泛网络约有1600万成员。。

At the core of Tempus' offerings is a comprehensive molecular profiling portfolio that equips physicians with tailored solutions to help optimize treatment decisions throughout each patient’s clinical care journey. The inclusion of Tempus' assays in Cigna's in-network coverage is poised to facilitate broader access to precision oncology care.

Tempus产品的核心是一个全面的分子分析组合,为医生提供量身定制的解决方案,以帮助优化每位患者在整个临床护理过程中的治疗决策。将Tempus的检测纳入信诺的网络覆盖范围,将有助于更广泛地获得精准的肿瘤护理。

Notably, this may result in reduced out-of-pocket costs for patients undergoing such testing, aligning with the specifics of their individual plans..

值得注意的是,这可能会降低接受此类测试的患者的自付费用,并与他们个人计划的具体情况保持一致。。

“Comprehensive molecular profiling is a critical tool for physicians seeking to optimize their patients’ treatment plan, so we are thrilled to broaden access to this technology to Cigna’s many members across the country,” said Ezra Cohen, MD, Chief Medical Officer of Oncology at Tempus.

Tempus肿瘤学首席医学官Ezra Cohen医学博士说:“对于寻求优化患者治疗计划的医生来说,全面的分子谱分析是一个至关重要的工具,因此我们很高兴能将这项技术的使用范围扩大到全国各地的信诺会员。”。

About Tempus

关于Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Tempus是一家通过人工智能在医疗保健中的实际应用来推进精准医学的技术公司。Tempus拥有世界上最大的多模式数据库之一,并拥有一个可访问和有用的操作系统,为医生提供支持AI的精准医学解决方案,以提供个性化的患者护理,同时促进最佳治疗方法的发现,开发和交付。

The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com..

目标是通过为医生提供工具,让每位患者在公司收集更多数据时学习,从而从之前的其他患者的治疗中受益。有关更多信息,请访问tempus.com。。